{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:39:47Z","timestamp":1792712387192,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001787","name":"Parker Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007202","name":"UV Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007491","name":"Donald E. and Delia B. Baxter Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Human leukocyte antigens (HLAs) are encoded by the most polymorphic genes in the human genome. HLA class I alleles control antigen presentation for T cell recognition, which is pivotal for autoimmunity, infectious diseases and cancer. Current knowledge of HLA-bound peptides is limited, skewed and falls short of population-wide HLA binding profiles for high-value targets. Here we present ESCAPE-seq (enhanced single-chain antigen presentation sequencing), a massively parallel platform for comprehensive screening of class I HLA\u2013peptide combinations for antigen presentation via deep DNA sequencing. ESCAPE-seq demonstrates programmability, high throughput, sensitivity and nominated viral and cancer epitopes. We simultaneously assessed over 75,000 peptide\u2013HLA combinations, revealing broadly presented epitopes from oncogenic driver mutations and fusions across diverse <jats:italic>HLA-A<\/jats:italic>, <jats:italic>HLA-B<\/jats:italic> and <jats:italic>HLA-C<\/jats:italic> alleles that cover 90% of the human population. We further identified epitopes that are differentially presented, comparing oncogenic hotspot mutations versus wild type. ESCAPE-seq enables one-shot population-wide antigen presentation discovery, offering insights into HLA specificity and immune recognition of genomic mutations.<\/jats:p>","DOI":"10.1038\/s41588-025-02268-1","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T09:03:40Z","timestamp":1753693420000},"page":"2062-2073","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Massively parallel immunopeptidome by DNA sequencing provides insights into cancer antigen presentation"],"prefix":"10.1038","volume":"57","author":[{"given":"Quanming","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2433-4390","authenticated-orcid":false,"given":"Elana P.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7834-4792","authenticated-orcid":false,"given":"Cansu","family":"Cimen Bozkus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kaminska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandra","family":"Velazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansi","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4724-6158","authenticated-orcid":false,"given":"Julia A.","family":"Belk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6130-0291","authenticated-orcid":false,"given":"Nuoya","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaowen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonglu","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4326-4084","authenticated-orcid":false,"given":"Robert R.","family":"Stickels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles R.","family":"Crain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0711-3570","authenticated-orcid":false,"given":"Laura","family":"Schmidt-Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl F.","family":"Lichti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6875-4472","authenticated-orcid":false,"given":"Gaurav D.","family":"Gaiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3970-9573","authenticated-orcid":false,"given":"Theodore L.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1865-4187","authenticated-orcid":false,"given":"Nina","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5167-537X","authenticated-orcid":false,"given":"Ansuman T.","family":"Satpathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5550-6701","authenticated-orcid":false,"given":"Bingfei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9459-4393","authenticated-orcid":false,"given":"Howard Y.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"2268_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/jhg.2008.5","volume":"54","author":"T Shiina","year":"2009","unstructured":"Shiina, T., Hosomichi, K., Inoko, H. & Kulski, J. K. The HLA genomic loci map: expression, interaction, diversity and disease. J. Hum. Genet. 54, 15\u201339 (2009).","journal-title":"J. Hum. Genet."},{"key":"2268_CR2","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev.immunol.16.1.323","volume":"16","author":"E Pamer","year":"1998","unstructured":"Pamer, E. & Cresswell, P. Mechanisms of MHC class I\u2013restricted antigen processing. Annu. Rev. Immunol. 16, 323\u2013358 (1998).","journal-title":"Annu. Rev. Immunol."},{"key":"2268_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/nrg.2015.33","volume":"17","author":"M Gutierrez-Arcelus","year":"2016","unstructured":"Gutierrez-Arcelus, M., Rich, S. S. & Raychaudhuri, S. Autoimmune diseases \u2013 connecting risk alleles with molecular traits of the immune system. Nat. Rev. Genet. 17, 160\u2013174 (2016).","journal-title":"Nat. Rev. Genet."},{"key":"2268_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1126\/science.272.5258.67","volume":"272","author":"P Parham","year":"1996","unstructured":"Parham, P. & Ohta, T. Population biology of antigen presentation by MHC class I molecules. Science 272, 67\u201374 (1996).","journal-title":"Science"},{"key":"2268_CR5","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nri3084","volume":"11","author":"J Neefjes","year":"2011","unstructured":"Neefjes, J., Jongsma, M. L. M., Paul, P. & Bakke, O. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat. Rev. Immunol. 11, 823\u2013836 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"2268_CR6","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.141264","volume":"5","author":"MG Klatt","year":"2020","unstructured":"Klatt, M. G. et al. Solving an MHC allele\u2013specific bias in the reported immunopeptidome. JCI Insight 5, e141264 (2020).","journal-title":"JCI Insight"},{"key":"2268_CR7","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.4049\/jimmunol.1600808","volume":"197","author":"M Bassani-Sternberg","year":"2016","unstructured":"Bassani-Sternberg, M. & Gfeller, D. Unsupervised HLA peptidome deconvolution improves ligand prediction accuracy and predicts cooperative effects in peptide-HLA interactions. J. Immunol. 197, 2492\u20132499 (2016).","journal-title":"J. Immunol."},{"key":"2268_CR8","doi-asserted-by":"publisher","first-page":"4690","DOI":"10.1172\/JCI88590","volume":"126","author":"H Pearson","year":"2016","unstructured":"Pearson, H. et al. MHC class I-associated peptides derive from selective regions of the human genome. J. Clin. Invest. 126, 4690\u20134701 (2016).","journal-title":"J. Clin. Invest."},{"key":"2268_CR9","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1084\/jem.181.6.2085","volume":"181","author":"JA McCutcheon","year":"1995","unstructured":"McCutcheon, J. A., Gumperz, J., Smith, K. D., Lutz, C. T. & Parham, P. Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA. J. Exp. Med. 181, 2085\u20132095 (1995).","journal-title":"J. Exp. Med."},{"key":"2268_CR10","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.4049\/jimmunol.1700893","volume":"199","author":"V Jurtz","year":"2017","unstructured":"Jurtz, V. et al. NetMHCpan-4.0: improved peptide-MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data. J. Immunol. 199, 3360\u20133368 (2017).","journal-title":"J. Immunol."},{"key":"2268_CR11","doi-asserted-by":"publisher","first-page":"e2338612","DOI":"10.1001\/jamanetworkopen.2023.38612","volume":"6","author":"T Olivier","year":"2023","unstructured":"Olivier, T., Haslam, A., Tuia, J. & Prasad, V. Eligibility for human leukocyte antigen-based therapeutics by race and ethnicity. JAMA Netw. Open 6, e2338612 (2023).","journal-title":"JAMA Netw. Open"},{"key":"2268_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0022-1759(97)00184-1","volume":"210","author":"A Schmittel","year":"1997","unstructured":"Schmittel, A., Keilholz, U. & Scheibenbogen, C. Evaluation of the interferon-\u03b3 ELISPOT-assay for quantification of peptide specific T lymphocytes from peripheral blood. J. Immunol. Methods 210, 167\u2013174 (1997).","journal-title":"J. Immunol. Methods"},{"key":"2268_CR13","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1002\/pro.4082","volume":"30","author":"M Darwish","year":"2021","unstructured":"Darwish, M. et al. High-throughput identification of conditional MHCI ligands and scaled-up production of conditional MHCI complexes. Protein Sci. 30, 1169\u20131183 (2021).","journal-title":"Protein Sci."},{"key":"2268_CR14","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.4049\/jimmunol.1900889","volume":"204","author":"AK Haj","year":"2020","unstructured":"Haj, A. K. et al. High-throughput identification of MHC class I binding peptides using an ultradense peptide array. J. Immunol. 204, 1689\u20131696 (2020).","journal-title":"J. Immunol."},{"key":"2268_CR15","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/s41587-023-01945-y","volume":"42","author":"HR Gurung","year":"2024","unstructured":"Gurung, H. R. et al. Systematic discovery of neoepitope-HLA pairs for neoantigens shared among patients and tumor types. Nat. Biotechnol. 42, 1107\u20131117 (2024).","journal-title":"Nat. Biotechnol."},{"key":"2268_CR16","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/s41587-022-01566-x","volume":"41","author":"PM Bruno","year":"2023","unstructured":"Bruno, P. M. et al. High-throughput, targeted MHC class I immunopeptidomics using a functional genetics screening platform. Nat. Biotechnol. 41, 980\u2013992 (2023).","journal-title":"Nat. Biotechnol."},{"key":"2268_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0022-1759(02)00346-0","volume":"271","author":"TF Greten","year":"2002","unstructured":"Greten, T. F. et al. Peptide\u2013\u03b22-microglobulin\u2013MHC fusion molecules bind antigen-specific T cells and can be used for multivalent MHC\u2013Ig complexes. J. Immunol. Methods 271, 125\u2013135 (2002).","journal-title":"J. Immunol. Methods"},{"key":"2268_CR18","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.4049\/jimmunol.168.7.3145","volume":"168","author":"YYL Yu","year":"2002","unstructured":"Yu, Y. Y. L., Netuschil, N., Lybarger, L., Connolly, J. M. & Hansen, T. H. Cutting Edge: Single-chain trimers of MHC class I molecules form stable structures that potently stimulate antigen-specific T cells and B cells. J. Immunol. 168, 3145\u20133149 (2002).","journal-title":"J. Immunol."},{"key":"2268_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-023-04899-8","volume":"6","author":"W Chour","year":"2023","unstructured":"Chour, W. et al. Large libraries of single-chain trimer peptide-MHCs enable antigen-specific CD8+ T cell discovery and analysis. Commun. Biol. 6, 1\u201313 (2023).","journal-title":"Commun. Biol."},{"key":"2268_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1170462","volume":"14","author":"KAK Finton","year":"2023","unstructured":"Finton, K. A. K. et al. Effects of HLA single chain trimer design on peptide presentation and stability. Front. Immunol. 14, 1170462 (2023).","journal-title":"Front. Immunol."},{"key":"2268_CR21","doi-asserted-by":"publisher","first-page":"6280","DOI":"10.4049\/jimmunol.178.10.6280","volume":"178","author":"SM Truscott","year":"2007","unstructured":"Truscott, S. M. et al. Disulfide bond engineering to trap peptides in the MHC class I binding groove. J. Immunol. 178, 6280\u20136289 (2007).","journal-title":"J. Immunol."},{"key":"2268_CR22","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1146\/annurev-immunol-032712-095910","volume":"31","author":"JS Blum","year":"2013","unstructured":"Blum, J. S., Wearsch, P. A. & Cresswell, P. Pathways of antigen processing. Annu. Rev. Immunol. 31, 443\u2013473 (2013).","journal-title":"Annu. Rev. Immunol."},{"key":"2268_CR23","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41577-022-00707-2","volume":"22","author":"N Pishesha","year":"2022","unstructured":"Pishesha, N., Harmand, T. J. & Ploegh, H. L. A guide to antigen processing and presentation. Nat. Rev. Immunol. 22, 751\u2013764 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"2268_CR24","doi-asserted-by":"publisher","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","volume":"48","author":"B Reynisson","year":"2020","unstructured":"Reynisson, B., Alvarez, B., Paul, S., Peters, B. & Nielsen, M. NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Nucleic Acids Res. 48, W449\u2013W454 (2020).","journal-title":"Nucleic Acids Res."},{"key":"2268_CR25","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.immuni.2020.11.004","volume":"53","author":"S As","year":"2020","unstructured":"As, S. et al. SARS-CoV-2 epitopes are recognized by a public and diverse repertoire of human T cell receptors. Immunity 53, 1245\u20131257 (2020).","journal-title":"Immunity"},{"key":"2268_CR26","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","volume":"183","author":"T Sekine","year":"2020","unstructured":"Sekine, T. et al. Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell 183, 158\u2013168 (2020).","journal-title":"Cell"},{"key":"2268_CR27","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41587-019-0322-9","volume":"38","author":"S Sarkizova","year":"2020","unstructured":"Sarkizova, S. et al. A large peptidome dataset improves HLA class I epitope prediction across most of the human population. Nat. Biotechnol. 38, 199\u2013209 (2020).","journal-title":"Nat. Biotechnol."},{"key":"2268_CR28","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate, J. G. et al. COSMIC: the Catalogue Of Somatic Mutations In Cancer. Nucleic Acids Res. 47, D941\u2013D947 (2019).","journal-title":"Nucleic Acids Res."},{"key":"2268_CR29","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMoa1609279","volume":"375","author":"E Tran","year":"2016","unstructured":"Tran, E. et al. T-cell transfer therapy targeting mutant KRAS in cancer. N. Engl. J. Med. 375, 2255\u20132262 (2016).","journal-title":"N. Engl. J. Med."},{"key":"2268_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2021.100084","volume":"1","author":"J Choi","year":"2021","unstructured":"Choi, J. et al. Systematic discovery and validation of T cell targets directed against oncogenic KRAS mutations. Cell Rep. Methods 1, 100084 (2021).","journal-title":"Cell Rep. Methods"},{"key":"2268_CR31","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.gene.2010.08.009","volume":"469","author":"RP Smyth","year":"2010","unstructured":"Smyth, R. P. et al. Reducing chimera formation during PCR amplification to ensure accurate genotyping. Gene 469, 45\u201351 (2010).","journal-title":"Gene"},{"key":"2268_CR32","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1128\/JVI.74.3.1234-1240.2000","volume":"74","author":"AE Jetzt","year":"2000","unstructured":"Jetzt, A. E. et al. High rate of recombination throughout the human immunodeficiency virus type 1 genome. J. Virol. 74, 1234\u20131240 (2000).","journal-title":"J. Virol."},{"key":"2268_CR33","first-page":"D783","volume":"48","author":"FF Gonzalez-Galarza","year":"2020","unstructured":"Gonzalez-Galarza, F. F. et al. Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools. Nucleic Acids Res. 48, D783\u2013D788 (2020).","journal-title":"Nucleic Acids Res."},{"key":"2268_CR34","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.3389\/fimmu.2018.01716","volume":"9","author":"D Gfeller","year":"2018","unstructured":"Gfeller, D. & Bassani-Sternberg, M. Predicting antigen presentation\u2014what could we learn from a million peptides? Front. Immunol. 9, 1716 (2018).","journal-title":"Front. Immunol."},{"key":"2268_CR35","doi-asserted-by":"publisher","first-page":"1067463","DOI":"10.3389\/fimmu.2022.1067463","volume":"13","author":"V Karnaukhov","year":"2022","unstructured":"Karnaukhov, V. et al. HLA variants have different preferences to present proteins with specific molecular functions which are complemented in frequent haplotypes. Front. Immunol. 13, 1067463 (2022).","journal-title":"Front. Immunol."},{"key":"2268_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2172-9-1","volume":"9","author":"J Sidney","year":"2008","unstructured":"Sidney, J., Peters, B., Frahm, N., Brander, C. & Sette, A. HLA class I supertypes: a revised and updated classification. BMC Immunol. 9, 1 (2008).","journal-title":"BMC Immunol."},{"key":"2268_CR37","doi-asserted-by":"publisher","first-page":"4487","DOI":"10.1093\/nar\/gkw282","volume":"44","author":"NS Latysheva","year":"2016","unstructured":"Latysheva, N. S. & Babu, M. M. Discovering and understanding oncogenic gene fusions through data intensive computational approaches. Nucleic Acids Res. 44, 4487\u20134503 (2016).","journal-title":"Nucleic Acids Res."},{"key":"2268_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37438-4","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication. Nat. Commun. 14, 1739 (2023).","journal-title":"Nat. Commun."},{"key":"2268_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.644520","volume":"12","author":"H Zhang","year":"2021","unstructured":"Zhang, H. et al. Identification of NY-ESO-1157-165 specific murine T cell receptors with distinct recognition pattern for tumor immunotherapy. Front. Immunol. 12, 644520 (2021).","journal-title":"Front. Immunol."},{"key":"2268_CR40","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1074\/jbc.M111.289488","volume":"287","author":"L Wooldridge","year":"2012","unstructured":"Wooldridge, L. et al. A single autoimmune T cell receptor recognizes more than a million different peptides. J. Biol. Chem. 287, 1168\u20131177 (2012).","journal-title":"J. Biol. Chem."},{"key":"2268_CR41","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.cell.2014.03.047","volume":"157","author":"ME Birnbaum","year":"2014","unstructured":"Birnbaum, M. E. et al. Deconstructing the peptide-MHC specificity of T cell recognition. Cell 157, 1073\u20131087 (2014).","journal-title":"Cell"},{"key":"2268_CR42","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1038\/s43018-023-00642-8","volume":"4","author":"E Giannakopoulou","year":"2023","unstructured":"Giannakopoulou, E. et al. A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo. Nat. Cancer 4, 1474\u20131490 (2023).","journal-title":"Nat. Cancer"},{"key":"2268_CR43","doi-asserted-by":"publisher","first-page":"e78389","DOI":"10.1371\/journal.pone.0078389","volume":"8","author":"T Yamada","year":"2013","unstructured":"Yamada, T. et al. EGFR T790M mutation as a possible target for immunotherapy; identification of HLA-A*0201-restricted T cell epitopes derived from the EGFR T790M mutation. PLoS ONE 8, e78389 (2013).","journal-title":"PLoS ONE"},{"key":"2268_CR44","doi-asserted-by":"publisher","first-page":"D423","DOI":"10.1093\/nar\/gku1161","volume":"43","author":"J Robinson","year":"2015","unstructured":"Robinson, J. et al. The IPD and IMGT\/HLA database: allele variant databases. Nucleic Acids Res. 43, D423\u2013D431 (2015).","journal-title":"Nucleic Acids Res."},{"key":"2268_CR45","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.4049\/jimmunol.172.5.2944","volume":"172","author":"HD Hickman","year":"2004","unstructured":"Hickman, H. D. et al. Toward a definition of self: proteomic evaluation of the class I peptide repertoire. J. Immunol. 172, 2944\u20132952 (2004).","journal-title":"J. Immunol."},{"key":"2268_CR46","doi-asserted-by":"publisher","first-page":"539","DOI":"10.4049\/jimmunol.1901173","volume":"205","author":"A Sachs","year":"2020","unstructured":"Sachs, A. et al. Impact of cysteine residues on MHC binding predictions and recognition by tumor-reactive T cells. J. Immunol. 205, 539\u2013549 (2020).","journal-title":"J. Immunol."},{"key":"2268_CR47","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3389\/fimmu.2019.00061","volume":"10","author":"PR Kennedy","year":"2019","unstructured":"Kennedy, P. R., Barthen, C., Williamson, D. J. & Davis, D. M. HLA-B and HLA-C differ in their nanoscale organization at cell surfaces. Front. Immunol. 10, 61 (2019).","journal-title":"Front. Immunol."},{"key":"2268_CR48","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s43018-021-00210-y","volume":"2","author":"AH Pearlman","year":"2021","unstructured":"Pearlman, A. H. et al. Targeting public neoantigens for cancer immunotherapy. Nat. Cancer 2, 487\u2013497 (2021).","journal-title":"Nat. Cancer"},{"key":"2268_CR49","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/s41587-023-01945-y","volume":"42","author":"HR Gurung","year":"2024","unstructured":"Gurung, H. R. et al. Systematic discovery of neoepitope\u2013HLA pairs for neoantigens shared among patients and tumor types. Nat. Biotechnol. 42, 1107\u20131117 (2024).","journal-title":"Nat. Biotechnol."},{"key":"2268_CR50","doi-asserted-by":"publisher","first-page":"e002531","DOI":"10.1136\/jitc-2021-002531","volume":"9","author":"F Li","year":"2021","unstructured":"Li, F. et al. Neoantigen vaccination induces clinical and immunologic responses in non-small cell lung cancer patients harboring EGFR mutations. J. Immunother. Cancer 9, e002531 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"2268_CR51","doi-asserted-by":"publisher","first-page":"4904","DOI":"10.1016\/j.cell.2022.11.016","volume":"185","author":"B Yu","year":"2022","unstructured":"Yu, B. et al. Engineered cell entry links receptor biology with single-cell genomics. Cell 185, 4904\u20134920.e22 (2022).","journal-title":"Cell"},{"key":"2268_CR52","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.cell.2019.07.009","volume":"178","author":"T Kula","year":"2019","unstructured":"Kula, T. et al. T-Scan: a genome-wide method for the systematic discovery of T cell epitopes. Cell 178, 1016\u20131028 (2019).","journal-title":"Cell"},{"key":"2268_CR53","doi-asserted-by":"publisher","first-page":"100758","DOI":"10.1016\/j.xpro.2021.100758","volume":"2","author":"C Cimen Bozkus","year":"2021","unstructured":"Cimen Bozkus, C., Blazquez, A. B., Enokida, T. & Bhardwaj, N. A T-cell-based immunogenicity protocol for evaluating human antigen-specific responses. STAR Protoc. 2, 100758 (2021).","journal-title":"STAR Protoc."}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41588-025-02268-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-025-02268-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-025-02268-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T18:46:54Z","timestamp":1757270814000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41588-025-02268-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["2268"],"URL":"https:\/\/doi.org\/10.1038\/s41588-025-02268-1","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"9 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Stanford University has filed a patent based on this work in which Q.S., B.Y. and H.Y.C. are named as inventors. H.Y.C. is a co-founder of Accent Therapeutics, Boundless Bio, Cartography Biosciences and Orbital Therapeutics, and an advisor to 10x Genomics, Arsenal Biosciences, Chroma Medicine and Exai Bio until 15 December 2024. H.Y.C. is an employee and stockholder of Amgen as of 16 December 2024. T.L.R. is a co-founder and former Chief Scientific Officer of Arsenal Bioscience, and an advisor to NewLimit. A.T.S. is a co-founder of Immunai, Cartography Biosciences, Santa Ana Bio and Prox Biosciences, is an advisor to 10x Genomics and Wing Venture Capital, and receives research funding from Astellas Pharma. N.B. is an extramural PICI member. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}